Literature DB >> 7875220

Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport.

V Cerundolo1, A Kelly, T Elliott, J Trowsdale, A Townsend.   

Abstract

The B cell line 721.174 has lost the ability to present intracellular antigens to major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes (CTL). This phenotype results from a homozygous deletion in the MHC that includes the peptide transporter genes TAP1 and TAP2, and the proteasome subunits LMP2 and LMP7. Recent work has shown that such cells transfected with TAP genes load their class I molecules with endogenous peptides, and present several viral epitopes to class I-restricted CTL. These data implied that the LMP2 and LMP7 genes were not required for the presentation of most epitopes through class I molecules. By contrast, while confirming the previous reports, we have identified several epitopes that appear to require genes in the MHC in addition to the TAP for their presentation. Further analysis localizes the defect to proteolysis in the cytosol. In one case, presentation could be partially restored by re-expression of full-length LMP7. Control experiments with LMP7, from which the putative pro-region had been removed, failed to restore presentation, and this lack of effect correlated with failure of the shortened LMP7 to incorporate into the proteasome. These results suggest a role for LMP7 in the generation of a viral epitope, but leave open the possibility that additional genes within the .174 deletion are required for full restoration of antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875220     DOI: 10.1002/eji.1830250238

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome.

Authors:  M Groettrup; S Standera; R Stohwasser; P M Kloetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.

Authors:  Sylvia Heink; Daniela Ludwig; Peter-M Kloetzel; Elke Krüger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-08       Impact factor: 11.205

3.  Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.

Authors:  Yoshinori Ito; Eisei Kondo; Ayako Demachi-Okamura; Yoshiki Akatsuka; Kunio Tsujimura; Mitsune Tanimoto; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits.

Authors:  D Nandi; E Woodward; D B Ginsburg; J J Monaco
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 5.  Functional regulation of immunoproteasomes and transporter associated with antigen processing.

Authors:  L Y Hwang; P T Lieu; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 6.  Structural and functional properties of proteasome activator PA28.

Authors:  L Kuehn; B Dahlmann
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 7.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

8.  Distinct Elements in the Proteasomal β5 Subunit Propeptide Required for Autocatalytic Processing and Proteasome Assembly.

Authors:  Xia Li; Yanjie Li; Cassandra S Arendt; Mark Hochstrasser
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

9.  Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.

Authors:  Ramon Kaneno; Galina V Shurin; Felipe M Kaneno; Hiam Naiditch; Jianhua Luo; Michael R Shurin
Journal:  Cell Oncol (Dordr)       Date:  2011-01-20       Impact factor: 6.730

10.  Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

Authors:  D Valmori; U Gileadi; C Servis; P R Dunbar; J C Cerottini; P Romero; V Cerundolo; F Lévy
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.